Insider Transactions Reported by 20 Insiders of Nuvation Bio Inc.

Symbol
NUVB, NUVB-WT on NYSE
Location
New York, NY

Insiders trading volume in the past year

Nuvation Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Omega Fund V, L.P. 10%+ Owner $114,561,104 05 Apr 2022
David Hung PRESIDENT AND CEO, Director, 10%+ Owner $105,935,243 +$1,713,720 +1.6% 16 Jun 2025
Xiangmin Cui Director $77,084,684 03 Sep 2024
Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director $17,665,663 11 Nov 2024
OLEG NODELMAN Director $17,251,636 19 Sep 2023
DANIEL G. WELCH Director $1,082,313 24 May 2024
Dongfang Liu Chief Medical Officer $1,071,990 -$1,666,381 -61% 01 Dec 2025
KIM BLICKENSTAFF Director $500,089 21 May 2025
Robert Mashal Director $333,980 +$166,985 +100% 11 Aug 2025
David C. Hanley Chief Technical Operations $171,321 -$1,427,680 -89% 19 Nov 2025
Colleen Sjogren Chief Commercial Officer $146,367 +$90,350 +161% 16 Jun 2025
Kerry Wentworth Chief Regulatory Officer $90,000 +$89,740 +34515% 16 Jun 2025
Stacy Markel Chief People Officer $50,600 +$17,100 +51% 18 Jun 2025
Moses Makunje Title: VP, Finance and principal financial and accounting officer. $44,145 28 Feb 2025
Philippe Sauvage Chief Financial Officer $17,724 +$13,216 +293% 16 Jun 2025
Jennifer Fox Chief Financial Officer $6,099 28 Feb 2023
Gary Hattersley Chief Scientific Officer $0 -$3,169,592 -100% 20 Nov 2025
VERNON W ANTHONY Director 21 May 2025
Robert B. Bazemore Director 21 May 2025
KATHRYN E. FALBERG Director 21 May 2025

Recent Insider Transactions by Companies or Individuals for Nuvation Bio Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.